Results 31 to 40 of about 19,123,678 (263)

Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin [PDF]

open access: yes, 2010
OBJECTIVE The aim of this study was to investigate whether apolipoprotein B100 of LDL suffers increased damage by glycation, oxidation, and nitration in patients with type 2 diabetes, including patients receiving metformin therapy.
Rabbani, Naila   +11 more
core   +1 more source

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins [PDF]

open access: yes, 2014
Statins effectively lower LDL cholesterol levels in large studies and the observed interindividual response variability may be partially explained by genetic variation.
Herrington, D.M.   +627 more
core   +2 more sources

Efficacy and Safety of Alirocumab as Add-on Therapy in High–Cardiovascular-Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg)::Design and Rationale of the ODYSSEY OPTIONS Studies [PDF]

open access: yes, 2014
The phase 3 ODYSSEY OPTIONS studies (OPTIONS I, NCT01730040; OPTIONS II, NCT01730053) are multicenter, multinational, randomized, double-blind, active-comparator, 24-week studies evaluating the efficacy and safety of alirocumab, a fully human monoclonal ...
Peter H. Jones   +13 more
core   +1 more source

Fasting Consequences during Ramadan on Lipid Profile and Dietary Patterns [PDF]

open access: yesJournal of Fasting and Health, 2013
Introduction: The aim was to assess the effects on lifestyle and lipid profile while fasting during holy month of Ramadan. Material and Methods: An interventional cohort study designed with 160 subjects who were fasting during Ramadan recruited from ...
Sondos Pirsaheb   +5 more
doaj   +4 more sources

Assessing the Validity of Friedewald’s Formula and Anandraja’s Formula For Serum Ldl-Cholesterol Calculation [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Introduction: An important aspect of the assessment of cardiovascular risk for a dyslipidemic subject is the estimation of serum Low-Density Lipoprotein Cholesterol (LDL-C).
P. KRISHNAVENI, VANITHA MN GOWDA
doaj   +1 more source

Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes

open access: yesJournal of Diabetes Research, 2015
Aims. To elucidate the levels of malondialdehyde-modified LDL (MDA-LDL)-related variables for predicting coronary artery stenosis (CAS) by coronary CT angiography (CCTA) in asymptomatic patients with type 2 diabetes (T2DM). Methods.
Kazuya Fujihara   +13 more
doaj   +1 more source

The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL

open access: yesBMC Cardiovascular Disorders, 2021
Background Lp(a) and LDL-C are both risk factors of atherosclerotic cardiovascular disease (ASCVD). But there was a contradiction point in LDL-C and Lp(a) control.
Chuang Li   +10 more
doaj   +1 more source

Success in achieving LDL-C target values in a high-risk population in Slovakia: SlovakLipid retrospective study

open access: yes, 2023
Introduction Slovakia is among the countries with the highest cardiovascular mortality; nevertheless, extensive data on the effectiveness of dyslipidaemia management are lacking.
Stefan Toth, Martin Turek, Daniel Pella
core   +1 more source

Impact of Adoption of Directly Measured Low-Density Lipoprotein-Cholesterol (LDL-C) on Targets of Lipid Control and Its Comparison With Friedewald Formula-Calculated LDL Cholesterol in People With Type-2 Diabetes Mellitus

open access: yesIndian Journal of Clinical Cardiology, 2021
Objectives: The accurate and precise measurement of low-density lipoprotein-cholesterol (LDL-C) is important in the assessment of atherosclerotic cardiovascular disease risk (ASCVD) in people with diabetes mellitus.
Rejitha Jagesh   +4 more
doaj   +1 more source

In silico and in vitro exploration of a tyrosinase for biocatalytic production of catechols

open access: yesFEBS Open Bio, EarlyView.
Tyrosinase from Ralstonia pseudosolanacearum is a promising biocatalyst for producing valuable catechols from monophenol substrates. This tyrosinase is uniquely suited to this due to its high monophenolase : diphenolase ratio. We combined in silico docking and in vivo kinetic characterisation of this tyrosinase with 11 industrially relevant monophenols,
James Britton   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy